Clinical Trials

Showing trials with last updates posted in 2014.

NCT01492920 | WITHDRAWN | PHASE3
0 participants

Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-31
Start Date:
2012-04-30
Completion:
2015-05-31
Conditions
  • Fatigue
  • Malignant Ovarian Mixed Epithelial Tumor
  • Neuropathy
  • Neurotoxicity Syndrome
  • Ovarian Brenner Tumor
  • Ovarian Clear Cell Cystadenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Mucinous Cystadenocarcinoma
  • Ovarian Serous Cystadenocarcinoma
  • Pain
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
Interventions
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
NCT01158287 | COMPLETED | PHASE2
54 participants

Sorafenib. ICORG 06-41, V4

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-31
Start Date:
2009-02-28
Completion:
2012-11-30
Conditions
  • Esophageal Cancer
  • Gastric Cancer
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00968682 | COMPLETED
480 participants

CADY Study ICORG 08-01

Study Type:
OBSERVATIONAL
Last Updated:
2014-12-31
Start Date:
2008-04-30
Completion:
2014-04-30
Conditions
  • Breast Cancer
  • Cardiac Toxicity
Interventions
  • BIOLOGICAL
  • OTHER
  • PROCEDURE
No Results Yet
NCT00968643 | COMPLETED | PHASE3
126 participants

Spinal Cord Compression. ICORG 05-03, V6

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-31
Start Date:
2006-01-31
Completion:
2014-05-31
Conditions
  • Spinal Cord Compression
  • Unspecified Adult Solid Tumor, Protocol Specific
Interventions
  • RADIATION
No Results Yet
NCT00814541 | COMPLETED | PHASE2
53 participants

PAD. ICORG 05-01, V11

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-31
Start Date:
2005-12-31
Completion:
2009-06-30
Conditions
  • Multiple Myeloma and Plasma Cell Neoplasm
Interventions
  • DRUG
No Results Yet
NCT00814086 | COMPLETED | PHASE1
23 participants

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-31
Start Date:
2009-02-28
Completion:
2011-07-31
Conditions
  • Chemotherapeutic Agent Toxicity
  • Endometrial Adenocarcinoma
  • Fallopian Tube Carcinoma
  • Gastrointestinal Complication
  • Malignant Ovarian Mixed Epithelial Tumor
  • Neurotoxicity Syndrome
  • Ovarian Brenner Tumor
  • Ovarian Clear Cell Cystadenocarcinoma
  • Ovarian Mucinous Cystadenocarcinoma
  • Ovarian Serous Cystadenocarcinoma
  • Primary Peritoneal Carcinoma
  • Stage II Ovarian Cancer
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
  • Undifferentiated Ovarian Carcinoma
Interventions
  • DRUG
No Results Yet
NCT00352300 | COMPLETED | PHASE1
43 participants

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-31
Start Date:
2006-06-30
Completion:
2010-07-31
Conditions
  • Fallopian Tube Carcinoma
  • Infectious Disorder
  • Neutropenia
  • Ovarian Carcinosarcoma
  • Primary Peritoneal Carcinoma
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page